GovChime
Notice ID: ed3f19f5dfc840ca801651deebc90227Solicitation

RFP - Intranasal Nalmefene Drug-Device Combination

Archived on September 30, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
2:00 PM UTC−04:00
Posted
August 19, 2023
Notice type
Solicitation
Agency
Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Notice details

Office
ASPR BARDA DIV CONTRACTS MGMT & ACQ
Place of performance
Washington, DC, 20024
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75A50123R00003
Notice ID
ed3f19f5dfc840ca801651deebc90227

Description

The Office of the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) intends to use Project BioShield (PBS) to support to the procurement of an intranasal nalmefene drug-device combination product for use by adult and pediatric populations for the treatment of opioid, including fentanyl overdose. Please see attached solicitation. Amendment 1 provides responses to vendor questions.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75A50123R00003
  1. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. 2×
    SolicitationCurrentAug 1, 2023

    RFP - Intranasal Nalmefene Drug-Device Combination

    Notice ed3f19f5dfc840ca801651deebc90227 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75A50123R00003

Archive Date

Sep 30, 2023

Office Address

Washington, DC, 20515